Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth.

Peippo M, Gardberg M, Lamminen T, Kaipio K, Carpén O, Heuser VD.

Exp Cell Res. 2016 Dec 2. pii: S0014-4827(16)30402-5. doi: 10.1016/j.yexcr.2016.12.004. [Epub ahead of print]

2.

SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish population.

Pasanen P, Palin E, Pohjolan-Pirhonen R, Pöyhönen M, Rinne JO, Päivärinta M, Martikainen MH, Kaasinen V, Hietala M, Gardberg M, Saukkonen AM, Eerola-Rautio J, Kaakkola S, Lyytinen J, Tienari PJ, Paetau A, Suomalainen A, Myllykangas L.

Neurobiol Aging. 2016 Oct 19. pii: S0197-4580(16)30254-8. doi: 10.1016/j.neurobiolaging.2016.10.014. [Epub ahead of print]

PMID:
27838048
3.

FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome.

Gardberg M, Heuser VD, Koskivuo I, Koivisto M, Carpén O.

J Pathol Clin Res. 2016 Jan 21;2(1):41-52. doi: 10.1002/cjp2.34.

4.

Scedosporium apiospermum as a rare cause of central skull base osteomyelitis.

Jalava-Karvinen P, Nyman M, Gardberg M, Harju I, Hohenthal U, Oksi J.

Med Mycol Case Rep. 2016 Apr 7;11:28-30. doi: 10.1016/j.mmcr.2016.04.002.

5.

[Phenotype and incidence of Creutzfeldt-Jakob disease in Finland in 1997-2013].

Isotalo J, Gardberg M, Verkkoniemi-Ahola A, Paetau A, Martikainen MH, Korpela J, Rummukainen J, Jääskeläinen SK, Parkkola R, Kaasinen V.

Duodecim. 2015;131(5):465-74. Finnish.

PMID:
26237909
6.

Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.

Rinne P, Hellberg S, Kiugel M, Virta J, Li XG, Käkelä M, Helariutta K, Luoto P, Liljenbäck H, Hakovirta H, Gardberg M, Airaksinen AJ, Knuuti J, Saraste A, Roivainen A.

Mol Imaging Biol. 2016 Feb;18(1):99-108. doi: 10.1007/s11307-015-0873-1.

PMID:
26122428
7.

Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.

Kiviniemi A, Gardberg M, Frantzén J, Parkkola R, Vuorinen V, Pesola M, Minn H.

J Neurooncol. 2015 Sep;124(2):237-45. doi: 10.1007/s11060-015-1829-7.

PMID:
26033547
8.

Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy.

Kiviniemi A, Gardberg M, Frantzén J, Pesola M, Vuorinen V, Parkkola R, Tolvanen T, Suilamo S, Johansson J, Luoto P, Kemppainen J, Roivainen A, Minn H.

EJNMMI Res. 2015 Apr 22;5:25. doi: 10.1186/s13550-015-0106-2.

9.

Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.

Kaasinen V, Kangassalo N, Gardberg M, Isotalo J, Karhu J, Parkkola R, Sonninen P.

Neurol Sci. 2015 Jul;36(7):1251-3. doi: 10.1007/s10072-015-2184-3.

PMID:
25805708
10.

Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.

Kiviniemi A, Gardberg M, Autio A, Li XG, Heuser VD, Liljenbäck H, Käkelä M, Sipilä H, Kurkipuro J, Ylä-Herttuala S, Knuuti J, Minn H, Roivainen A.

Acta Oncol. 2014 Aug;53(8):1125-34. doi: 10.3109/0284186X.2014.925577.

PMID:
24957558
11.

Diagnostic accuracy of parkinsonism syndromes by general neurologists.

Joutsa J, Gardberg M, Röyttä M, Kaasinen V.

Parkinsonism Relat Disord. 2014 Aug;20(8):840-4. doi: 10.1016/j.parkreldis.2014.04.019.

PMID:
24816002
12.

Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues.

Gardberg M, Heuser VD, Iljin K, Kampf C, Uhlen M, Carpén O.

J Histochem Cytochem. 2014 Jun;62(6):460-470.

13.

FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion.

Gardberg M, Kaipio K, Lehtinen L, Mikkonen P, Heuser VD, Talvinen K, Iljin K, Kampf C, Uhlen M, Grénman R, Koivisto M, Carpén O.

PLoS One. 2013 Sep 26;8(9):e74923. doi: 10.1371/journal.pone.0074923.

14.

Brain glucose metabolism in neuropathologically confirmed multiple system atrophy.

Kaasinen V, Gardberg M, Seppänen M, Röyttä M, Parkkola R, Bergman J.

J Neurol. 2013 Jul;260(7):1922-4. doi: 10.1007/s00415-013-6967-2. No abstract available.

PMID:
23719789
15.

Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.

Kaasinen V, Gardberg M, Röyttä M, Seppänen M, Päivärinta M.

J Neurol. 2013 May;260(5):1410-1. doi: 10.1007/s00415-013-6886-2. No abstract available.

PMID:
23471615
16.

Statin-induced myopathy in a patient with previous poliomyelitis.

Martikainen MH, Gardberg M, Kohonen Ia, Lähdesmäki J.

Am J Phys Med Rehabil. 2013 Nov;92(11):1031-4. doi: 10.1097/PHM.0b013e318282d17e.

PMID:
23370588
17.

Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion.

Martikainen MH, Gardberg M, Jansson L, Röyttä M, Rinne JO, Kaasinen V.

Neurocase. 2014 Apr;20(2):150-7. doi: 10.1080/13554794.2012.741252.

PMID:
23216213
18.

Malpresentations--impact on mode of delivery.

Gardberg M, Leonova Y, Laakkonen E.

Acta Obstet Gynecol Scand. 2011 May;90(5):540-2. doi: 10.1111/j.1600-0412.2011.01105.x.

PMID:
21501123
19.

Characterization of Diaphanous-related formin FMNL2 in human tissues.

Gardberg M, Talvinen K, Kaipio K, Iljin K, Kampf C, Uhlen M, Carpén O.

BMC Cell Biol. 2010 Jul 15;11:55. doi: 10.1186/1471-2121-11-55.

20.

Sphincter rupture and anal incontinence.

Gardberg M.

Acta Obstet Gynecol Scand. 2005 Jul;84(7):709; author reply 710. No abstract available.

PMID:
15954887
Items per page

Supplemental Content

Loading ...
Support Center